IL-4 and IL-10 halt pro-inflammatory cytokine release from monocytes and synovial fibroblasts, and their levels were reduced in RA patients, as also evident in DC animals in the current study (Mateen et al., 2016). This evidence concerns the gene IL4 and rheumatoid arthritis.